The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Redox signaling, Nox5 and vascular remodeling in hypertension
Open accessAbstract
PURPOSE OF REVIEW: Extensive data indicate a role for reactive oxygen species (ROS) and redox signaling in vascular damage in hypertension. However, molecular mechanisms underlying these processes remain unclear, but oxidative post-translational modification of vascular proteins is critical. This review discusses how proteins are oxidatively modified and how redox signaling influences vascular smooth muscle cell growth and vascular remodeling in hypertension. We also highlight Nox5 as a novel vascular ROS-generating oxidase. RECENT FINDINGS: Oxidative stress in hypertension leads to oxidative imbalance that affects vascular cell function through redox signaling. Many Nox isoforms produce ROS in the vascular wall, and recent findings show that Nox5 may be important in humans. ROS regulate signaling by numerous processes including cysteine oxidative post-translational modification such as S-nitrosylation, S-glutathionylation and sulfydration. In vascular smooth muscle cells, this influences cellular responses to oxidative stimuli promoting changes from a contractile to a proliferative phenotype. SUMMARY: In hypertension, Nox-induced ROS production is increased, leading to perturbed redox signaling through oxidative modifications of vascular proteins. This influences mitogenic signaling and cell cycle regulation, leading to altered cell growth and vascular remodeling in hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NOX5 expression can be activated by most of the factors that activate other vascular NOX enzymes such as angiotensin II, TNF-α, PDGF, thrombin, and endothelin-1 (81, 660, 681).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [660]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
H 2 S as a Physiologic Vasorelaxant: Hypertension in Mice with Deletion of Cystathionine γ-Lyase
Yang, G., Wu, L., Jiang, B., Yang, W., Qi, J., Cao, K., Meng, Q., Mustafa, A. K., Mu, W., Zhang, S., et al. (2008) · Science · doi:10.1126/science.1162667 · Cited by 2,310
Superoxide Dismutases: Role in Redox Signaling, Vascular Function, and Diseases
Fukai, T., & Ushio‐Fukai, M. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3999 · Cited by 2,074
Superoxide Anion Radical (O·̄2), Superoxide Dismutases, and Related Matters
Fridovich, I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18515 · Cited by 1,337
Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an Antioxidant
Heumüller, S., Wind, S., Barbosa-Sicard, E., Schmidt, H. H. H. W., Busse, R., Schröder, K., & Brandes, R. P. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.100214 · Cited by 735
Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression.
Rao, G. N., & Berk, B. C. (1992) · Circulation Research · doi:10.1161/01.res.70.3.593 · Cited by 649
Molecular Mechanisms and Clinical Implications of Reversible Protein S -Glutathionylation
Mieyal, J. J., Gallogly, M. M., Qanungo, S., Sabens, E. A., & Shelton, M. D. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2089 · Cited by 523
Evolution of nadph oxidase inhibitors: Selectivity and mechanisms for target engagement
Altenhöfer, S., Radermacher, K. A., Kleikers, P. W. M., Wingler, K., & Schmidt, H. H. H. W. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5814 · Cited by 521
Regulation of Signal Transduction by Reactive Oxygen Species in the Cardiovascular System
Brown, D., & Griendling, K. K. (2015) · Circulation Research · doi:10.1161/circresaha.116.303584 · Cited by 498
NADPH Oxidases in Vascular Pathology
Konior, A., Schramm‐Luc, A., Cześnikiewicz‐Guzik, M., & Guzik, T. J. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5607 · Cited by 464
Krishnan, N., Fu, C., Pappin, D., & Tonks, N. K. (2011) · Science Signaling · doi:10.1126/scisignal.2002329 · Cited by 455
Angiotensin II and Vascular Injury
Montezano, A. C. I., Cat, A. N. D., Rios, F. J. O., & Touyz, R. M. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0431-2 · Cited by 412
Self-citationChen, X., Touyz, R. M., Park, J. B., & Schiffrin, E. L. (2001) · Hypertension · doi:10.1161/hy09t1.094005 · Cited by 410
Self-citationDalle‐Donne, I. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00749-3 · Cited by 398
Thomas, S. R., Witting, P. K., & Drummond, G. R. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2027 · Cited by 383
Go, Y., Chandler, J. D., & Jones, D. P. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.03.022 · Cited by 363
Oxidative Stress and Antioxidants in Hypertension–A Current Review
Sinha, N., & Dabla, P. K. (2015) · Current Hypertension Reviews · doi:10.2174/1573402111666150529130922 · Cited by 350
Antioxidants, inflammation and cardiovascular disease
Mangge, H. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i6.462 · Cited by 347
Schiffrin, E. L. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.05.023 · Cited by 334
Oxidative Stress and Human Hypertension: Vascular Mechanisms, Biomarkers, and Novel Therapies
Montezano, A. C. I., Dulak-Lis, M. G., Tsiropoulou, S., Harvey, A., Briones, A. M., & Touyz, R. M. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.02.008 · Cited by 324
Self-citationMontezano, A. C. I., & Touyz, R. M. (2011) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2011.00785.x · Cited by 320
Self-citationEndothelial NADPH oxidases: which NOX to target in vascular disease?
Drummond, G. R., & Sobey, C. G. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.06.012 · Cited by 315
Cysteine Oxidative Posttranslational Modifications
Chung, H. S., Wang, S.-B., Venkatraman, V., Murray, C. I., & Eyk, J. E. V. (2013) · Circulation Research · doi:10.1161/circresaha.112.268680 · Cited by 314
Guzik, T. J., Chen, W., Gongora, M. C., Guzik, B., Lob, H. E., Mangalat, D., Hoch, N., Dikalov, S., Rudzinski, P., Kapelak, B., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.063 · Cited by 281
Montezano, A. C. I., & Touyz, R. M. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5302 · Cited by 280
Self-citationGreco, T. M., Hodara, R., Parastatidis, I., Heijnen, H. F. G., Dennehy, M. K., Liebler, D. C., & Ischiropoulos, H. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600729103 · Cited by 259
Ghouleh, I. A., Khoo, N. K. H., Knaus, U. G., Griendling, K. K., Touyz, R. M., Thannickal, V. J., Barchowsky, A., Nauseef, W. M., Kelley, E. E., Bauer, P. M., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.011 · Cited by 252
Self-citationRedox Signaling, Vascular Function, and Hypertension
Lee, M. Y., & Griendling, K. K. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1986 · Cited by 249
Cantu-Medellin, N., & Kelley, E. E. (2013) · Redox Biology · doi:10.1016/j.redox.2013.05.002 · Cited by 237
Redox signaling in cardiovascular health and disease
Madamanchi, N. R., & Runge, M. S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.001 · Cited by 227
Reactive oxygen species and redox compartmentalization
Kaludercic, N., Deshwal, S., & Lisa, F. D. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00285 · Cited by 223
Role of mitochondrial oxidative stress in hypertension
Dikalov, S., & Ungvari, Z. I. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00089.2013 · Cited by 205
Angiotensin II and the vascular phenotype in hypertension
Savoia, C., Burger, D. E., Nishigaki, N., Montezano, A. C. I., & Touyz, R. M. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001815 · Cited by 203
Self-citationTouyz, R. M., Yao, G., Viel, É. C., Amiri, F., & Schiffrin, E. L. (2004) · Journal of Hypertension · doi:10.1097/00004872-200406000-00015 · Cited by 199
Self-citationOxidative stress, Noxs, and hypertension: Experimental evidence and clinical controversies
Montezano, A. C. I., & Touyz, R. M. (2012) · Annals of Medicine · doi:10.3109/07853890.2011.653393 · Cited by 196
Self-citationNox NADPH Oxidases and the Endoplasmic Reticulum
Laurindo, F. R. M., Araujo, T. L. S., & Abrahão, T. B. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5605 · Cited by 194
Montezano, A. C., Burger, D., Paravicini, T. M., Chignalia, A. Z., Yusuf, H., Almasri, M., He, Y., Callera, G. E., He, G., Krause, K.-H., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.216036 · Cited by 188
Self-citationRedox Regulation of Mitochondrial ATP Synthase
Wang, S.-B., Foster, D. B., Rucker, J. J., O'Rourke, B. P., Kass, D. A., & Eyk, J. E. V. (2011) · Circulation Research · doi:10.1161/circresaha.111.246124 · Cited by 166
Barnouin, K., Dubuisson, M., Child, E. S., de Mattos, S. F., Glassford, J., Medema, R. H., Mann, D. J., & Lam, E. W. ‐. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111123200 · Cited by 161
Nox5 and the Regulation of Cellular Function
Fulton, D. J. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2587 · Cited by 161
Oxidation of Myofibrillar Proteins in Human Heart Failure
Canton, M., Menazza, S., Sheeran, F. L., de Laureto, P. P., Lisa, F. D., & Pepe, S. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.058 · Cited by 159
Zweier, J. L., Chen, C., & Druhan, L. J. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.3904 · Cited by 147
SERRANDER, L., JAQUET, V, BEDARD, K., PLASTRE, O., HARTLEY, O., ARNAUDEAU, S., DEMAUREX, N., SCHLEGEL, W., & KRAUSE, K. (2007) · Biochimie · doi:10.1016/j.biochi.2007.05.004 · Cited by 146
Santos, C. X. C., Nabeebaccus, A., Shah, A. M., Camargo, L. L., Filho, S. V., & Lopes, L. R. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5262 · Cited by 143
Self-citationOelze, M. W., Kröller‐Schön, S., Steven, S., Lubos, E., Doppler, C. E. J., Hausding, M., Tobias, S., Brochhausen, C., Li, H., Torzewski, M., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01602 · Cited by 136
Nephropathy and Elevated BP in Mice with Podocyte-Specific NADPH Oxidase 5 Expression
Holterman, C. E., Thibodeau, J.-F., Towaij, C., Gutsol, A. A., Montezano, A. C. I., Parks, R. J., Cooper, M. E., Touyz, R. M., & Kennedy, C. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013040371 · Cited by 133
Self-citationNOX5: from basic biology to signaling and disease
Bedard, K., Jaquet, V., & Krause, K. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.023 · Cited by 126
Barman, S. A., Chen, F., Su, Y., Dimitropoulou, C., Wang, Y., Catravas, J. D., Han, W., Őrfi, L., Szántai-Kis, C., Kéri, G., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303848 · Cited by 124
Ashor, A. W., Siervo, M., Lara, J., Oggioni, C., Afshar, S., & Mathers, J. C. (2015) · British Journal Of Nutrition · doi:10.1017/s0007114515000227 · Cited by 112
Touyz, R. M., Cruzado, M., Tabet, F., Yao, G., Salomon, S., & Schiffrin, E. L. (2003) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y02-164 · Cited by 109
Self-citationNovel redox-dependent regulation of NOX5 by the tyrosine kinase c-Abl
Jamali, A. E., Valente, A. J., Lechleiter, J. D., Gamez, M. J., Pearson, D. W., Nauseef, W. M., & Clark, R. A. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.11.020 · Cited by 107
Redox Regulation of Protein Kinases as a Modulator of Vascular Function
Knock, G. A., & Ward, J. P. T. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3614 · Cited by 107
Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models
Rivera, J., Sobey, C. G., Walduck, A. K., & Drummond, G. R. (2010) · Redox Report · doi:10.1179/174329210x12650506623401 · Cited by 105
Nitric oxide reduces NADPH oxidase 5 (Nox5) activity by reversible S-nitrosylation
Qian, J., Chen, F., Kovalenkov, Y. O., Pandey, D., Moseley, M. A., Foster, M. W., Black, S. M., Venema, R. C., Stepp, D. W., & Fulton, D. J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.02.029 · Cited by 100
Atheroprotective effects of antioxidants through inhibition of mitogen-activated protein kinases.
Kyaw, M. H., Yoshizumi, M., Tsuchiya, K., Izawa, Y., Kanematsu, Y., & Tamaki, T. (2004) · PubMed · Cited by 96
NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS
Cifuentes-Pagano, E., Csányi, G., & Pagano, P. J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1009-2 · Cited by 94
Regulation of NADPH Oxidase 5 by Protein Kinase C Isoforms
Chen, F., Yu, Y., Haigh, S., Johnson, J. A., Lucas, R., Stepp, D. W., & Fulton, D. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088405 · Cited by 89
Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR
Briones, A. M., Tabet, F., Callera, G. E., Montezano, A. C. I., Yogi, Á., He, Y., Quinn, M. T., Salaíces, M., & Touyz, R. M. (2011) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2011.02.001 · Cited by 89
Self-citationAutophagic regulation of smooth muscle cell biology
Salabei, J. K., & Hill, B. G. (2014) · Redox Biology · doi:10.1016/j.redox.2014.12.007 · Cited by 86
Nox Family NADPH Oxidases in Mechano-Transduction: Mechanisms and Consequences
Brandes, R. P., Weißmann, N., & Schröder, K. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5414 · Cited by 84
The Quest for Selective Nox Inhibitors and Therapeutics: Challenges, Triumphs and Pitfalls
Cifuentes-Pagano, E., Meijles, D. N., & Pagano, P. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5620 · Cited by 84
Mackay, C., & Knock, G. A. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.285304 · Cited by 84
Chen, F., Pandey, D., Chadli, A., Catravas, J. D., Chen, T., & Fulton, D. J. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3669 · Cited by 81
Pandey, D., Patel, A., Patel, V., Chen, F., Qian, J., Wang, Y., Barman, S. A., Venema, R. C., Stepp, D. W., Daniel Rudic, R., et al. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00910.2011 · Cited by 81
Targeting NOX enzymes in the central nervous system: therapeutic opportunities
Sorce, S., Krause, K., & Jaquet, V. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1014-5 · Cited by 79
S-glutathionylation in human platelets by a thiol–disulfide exchange-independent mechanism
Dalle‐Donne, I., Giustarini, D., Colombo, R., Milzani, A., & Rossi, R. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.02.019 · Cited by 76
Hemodynamic Regulation of Reactive Oxygen Species: Implications for Vascular Diseases
Raaz, U., Toh, R., Mäegdefessel, L., Adam, M., Nakagami, F., Emrich, F. C., Spin, J. M., & Tsao, P. S. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5507 · Cited by 76
Manea, A., Manea, S.-A., Gan, A. M., Constantin, A., Fenyo, I. M., Raicu, M., Muresian, H., & Simionescu, M. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.04.021 · Cited by 69
Small artery remodeling in hypertension and diabetes
Rizzoni, D., & Rosei, E. A. (2006) · Current Hypertension Reports · doi:10.1007/s11906-006-0046-3 · Cited by 69
Hahn, N. E., Meischl, C., Kawahara, T., Musters, R. J. P., Verhoef, V. M. J., van der Velden, J., Vonk, A. B. A., Paulus, W. J., van Rossum, A. C., Niessen, H. W. M., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.02.018 · Cited by 67
Site-Mapping of In Vitro S-nitrosation in Cardiac Mitochondria: Implications for Cardioprotection
Murray, C. I., Kane, L. A., Uhrigshardt, H., Wang, S.-B., & Van Eyk, J. E. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.004721 · Cited by 63
MicroRNA‐365 Inhibits the Proliferation of Vascular Smooth Muscle Cells by Targeting Cyclin D1
Kim, M., Ham, O., Lee, S., Choi, E., Lee, C. Y., Park, J., Lee, J., Seo, H., Seung, M., Choi, E., et al. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24841 · Cited by 57
Role of Lipid Peroxidation-Derivedα,β-Unsaturated Aldehydes in Vascular Dysfunction
Lee, S. E., & Park, Y. S. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/629028 · Cited by 56
Molecular regulation of NADPH oxidase 5 via the MAPK pathway
Pandey, D., & Fulton, D. J. R. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01163.2010 · Cited by 55
Liu, B., Luo, X., Yang, Z., Zhang, J.-J., Li, T., Zhang, X., Ma, Q., Zhang, G., Hu, C., & Peng, J. (2014) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000082 · Cited by 54
Unique role of NADPH oxidase 5 in oxidative stress in human renal proximal tubule cells
Yu, P., Han, W., Villar, V. A. M., Yang, Y., Lu, Q., Lee, H., Li, F., Quinn, M. T., Gildea, J. J., Felder, R. A., et al. (2014) · Redox Biology · doi:10.1016/j.redox.2014.01.020 · Cited by 53
Oxidative Stress and Early Atherosclerosis: Novel Antioxidant Treatment
Tousoulis, D., Ψαλτοπούλου, Θ., Androulakis, E. S., Παπαγεωργίου, Ν., Papaioannou, S., Oikonomou, E. K., Synetos, A. G., & Stefanadis, C. (2014) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-014-6562-5 · Cited by 51
Bruder-Nascimento, T. B., Callera, G. E., Montezano, A. C. I., He, Y., Antunes, T. T., Cat, A. N. D., Tostes, R. C., & Touyz, R. M. (2014) · Clinical Science · doi:10.1042/cs20140456 · Cited by 49
Self-citationChatterjee, S., Fujiwara, K., Pérez, N. G., Ushio‐Fukai, M., & Fisher, A. B. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00105.2015 · Cited by 46
Tabet, F., Schiffrin, E. L., & Touyz, R. M. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000185715.60788.1b · Cited by 41
Self-citationThe Role of Vitamin Supplementation in the Prevention of Cardiovascular Disease Events
Desai, C., Huang, J. J., Lokhandwala, A. M., Fernandez, A., Riaz, I. B., & Alpert, J. S. (2014) · Clinical Cardiology · doi:10.1002/clc.22299 · Cited by 37
Gole, H. K. A., Tharp, D. L., & Bowles, D. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105337 · Cited by 36
Choi, H., Allahdadi, K. J., Tostes, R. C., & Webb, R. C. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834d2554 · Cited by 35
Wang, X., Ling, S., Zhao, D., et al. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2833 · Cited by 34
Scioli, M. G., Bielli, A., Agostinelli, S., Tarquini, C., Arcuri, G., Ferlosio, A., Costanza, G., Doldo, E., & Orlandi, A. (2014) · Journal of Vascular Research · doi:10.1159/000365926 · Cited by 32
Antioxidant Vitamin Intake and Mortality
Paganini‐Hill, A., Kawas, C. H., & Corrada, M. M. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu294 · Cited by 29
Androwiki, A. C. D., Camargo, L. L., Sartoretto, S., Couto, G. K., Ribeiro, I. M. R., Veríssimo-Filho, S., Rossoni, L. V., & Lopes, L. R. (2015) · Frontiers in Chemistry · doi:10.3389/fchem.2015.00024 · Cited by 25
Self-citationIL-22 activates oxidant signaling in pulmonary vascular smooth muscle cells
Bansal, G., Das, D., Hsieh, C., Wang, Y., Gilmore, B. A., Wong, C., & Suzuki, Y. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.09.001 · Cited by 24
Zhang, X., Liu, L., Chen, C., et al. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-147 · Cited by 24
Sabuhi, R., Asghar, M., & Hussain, T. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00310.2010 · Cited by 19
NADPH Oxidases: Progress and Opportunities
Martín, A. S., & Griendling, K. K. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5947 · Cited by 16
Kim, T. H., Oh, S. V., & Kim, S. S. (2006) · Angiogenesis · doi:10.1007/s10456-005-9020-y · Cited by 16
Sato, Y., Ikeda, M., Ito, T., Tomita, T., Yokotani, K., Murata, M., & Umegaki, K. (2011) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2010.549268 · Cited by 4
Research works printed but not linked: 3
- Lee, 2013, Oxid Med Cell Longev, 2013, 629028
- Drummond, 2014, etab, 25, 452
- Yoshizumi, 2004, Acta Pharmacol Sin, 25, 977
Cited by
Sorted by citations
Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis
Förstermann, U., Xia, N., & Li, H. (2017) · Circulation Research · doi:10.1161/circresaha.116.309326 · Cited by 1,519
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
Metadata
- Authors
- Montezano, A. C., Tsiropoulou, S., Dulak-Lis, M., Harvey, A., Camargo, L. D. L., & Touyz, R. M.
- Affiliations
- University of Glasgow (GB)
- Corresponding author
- Touyz, Rhian M.
- Venue
- Current Opinion in Nephrology and Hypertension
- Published
- 2015-09
- Volume
- 24
- Issue
- 5
- Pages
- 425-433
- ISSN
- 1062-4821 (ISSN-L)
- PMC
- PMC4727501
- OpenAlex
- W955847907
- Cited by
- 93
- References
- 92
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 4 · 2023: 5 · 2022: 7 · 2021: 6 · 2020: 14 · 2019: 14 · 2018: 10 · 2017: 15 · 2016: 10
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Current Opinion in Nephrology & Hypertension (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Funders
- British Heart Foundation (29762, RG/13/7/30099, 30099)
- Canadian Institutes of Health Research (44018, 57786)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- redox signaling, NADPH oxidase 5, reactive oxygen species, hypertension, vascular remodeling, oxidative post-translational modifications, S-nitrosylation, S-glutathionylation, cysteine oxidation, vascular smooth muscle cells, oxidative stress, NADPH oxidase, vascular cell proliferation
- MeSH terms
- NADPH Oxidase 5, Animals, Humans, Hypertension, Membrane Proteins, Oxidation-Reduction, Signal Transduction, Reactive Oxygen Species, NADPH Oxidases, Vascular Remodeling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review